大麻和精神病在多巴胺系统上的融合
Jessica Ahrens1,2, Sabrina D Ford3,4, Betsy Schaefer3,4
1Integrated Program in Neuroscience, McGill University, Montreal, Quebec, Canada.
JAMA psychiatry
|April 9, 2025
概括
大麻使用障碍与多巴胺功能的改变有关,可能增加精神病风险. 这项研究使用神经黑色素-MRI来显示大麻使用障碍患者的多巴胺标记物升高,这表明精神病症状的常见途径.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 放射学 放射学是指放射学
背景情况:
- 大麻使用障碍 (CUD) 与精神病风险增加有关.
- 多巴胺系统功能障碍与精神病有关,但与CUD的联系尚不清楚.
- 神经黑色素敏感MRI (神经黑色素-MRI) 提供了多巴胺功能的代理测量.
研究的目的:
- 通过使用神经黑色素-MRI,研究CUD患者的多巴胺系统变化.
- 为了确定这些变化是否存在于CUD患者和没有第一发精神分裂症 (FES) 的人.
主要方法:
- 从2019年到2023年进行了一项纵向观察队列研究.
- 参与者包括有和没有CUD的个人,有些人有FES.
- 中脑中神经黑色素-MRI信号 (黑质体/腹膜区域) 使用线性混合效应模型进行了分析.
主要成果:
- CUD与腹部黑质体/腹部体区域中神经黑色素-MRI信号的升高有关.
- 在CUD症状严重程度和神经黑色素-MRI信号之间观察到剂量依赖的关系.
- 单独的第一发精神分裂症 (FES) 没有显示神经黑色素-MRI信号的显著升高.
结论:
- 特定中脑区域的多巴胺功能升高可能与CUD患者的精神病风险有关.
- 大麻使用可能有助于精神病症状表达的常见途径.
相关概念视频
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
513
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
513
Psychosis and Antipsychotic Drugs: Overview
192
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
192
Hallucinogens and Psychedelics
158
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
158
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
167
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
167
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
204
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
204
Biological Causes of Schizophrenia
50
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
50


